Request Appointment
136 Mountainview BlvdBasking Ridge, NJ 07920
Fax+1 908-542-3222
Overview of Dr. Xiao
Dr. Han Xiao is an oncologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Overlook Medical Center. She received her medical degree from Sun Yat-Sen University of Medical Science and has been in practice 33 years. She is one of 524 doctors at Memorial Sloan Kettering Cancer Center and one of 52 doctors at Overlook Medical Center who specialize in Oncology. She has more than 60 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Rochester Regional Health/Unity Hospital (Rochester)Residency, Internal Medicine, 1991 - 1994
Sun Yat-Sen University of Medical ScienceClass of 1984
Certifications & Licensure
NJ State Medical License 2007 - 2027
NY State Medical License 1994 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
Publications & Presentations
PubMed
- Patients' Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study.Marco Santos Teles, Karolina Bryl, Susan Chimonas, Atif Khan, Andrew S Epstein
JMIR Cancer. 2026-02-04 - 1 citationsA phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage respon...Karen A Autio, Christos E Kyriakopoulos, Paul Palyca, Han Xiao, Hamid Emamekhoo
Investigational New Drugs. 2025-08-01 - 1 citationsOlaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer.Karen A Autio, Deaglan J McHugh, Dana E Rathkopf, Han Xiao, Swathi Merugu
Journal of Immunotherapy and Precision Oncology. 2025-05-01
Journal Articles
- Long‐Term Quality of Life in Older Patients with HPV‐Related Oropharyngeal CancerHan Xiao, Nancy Y Lee, Head & Neck
- Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast CancerHan Xiao, Travis S Young, Angewandte Chemie
Press Mentions
Targeted, Anti-Clotting Meds Had Less Risk of Major Bleeding for Rare, Deadly StrokesFebruary 10th, 2022- Drug Doubles down on Bone Cancer, MetastasisJune 23rd, 2021
- First Person Profile: George J. Bosl, MDJanuary 12th, 2021
Grant Support
- Engineering Proteins with Noncanonical Amino AcidsRICE UNIVERSITY2019–2029
- Modulation of Epigenetic Target in the Bone to Treat Breast Cancer MetastasisRICE UNIVERSITY2023–2028
- Modulation of Epigenetic Target in the Bone to Treat Breast Cancer MetastasisRICE UNIVERSITY2023–2028
- Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV InfectionNORTHWESTERN UNIVERSITY AT CHICAGO2021–2026
- Targeting Siglec-9/Sialoglycan Interactions to Enhance NK Functions During HIV InfectionNORTHWESTERN UNIVERSITY AT CHICAGO2021–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
